Key facts
- This page summarizes Jack Nielsen's Form 4 filing for REATA PHARMACEUTICALS INC.
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 14 Jun 2021, 11:26.
Jack Nielsen - 10 Jun 2021 Form 4 Insider Report for REATA PHARMACEUTICALS INC
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 10 Jun 2021
- Net transaction value
- +$99,971
- SEC form
- 4
- Accepted by SEC
- 14 Jun 2021, 11:26:03 UTC
- Prior SEC filing
- 14 Jun 2021
- Next SEC filing
- 15 Jun 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Tracy Herson, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jack Nielsen filed Form 4 for REATA PHARMACEUTICALS INC on 14 Jun 2021.
Change
- Previous filing in this sequence was filed on 14 Jun 2021.
- Current net transaction value: +$99,971.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RETA
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +5,000
- Change %
- Price
- $0.000000
- Shares after
- 5,000
- Date
- 10 Jun 2021
- Ownership
- Direct
- Underlying class
- Class A common stock
- Underlying amount
- 5,000
- Exercise price
- $146.01
- Footnotes
- F1
RETA
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $99,971
- Shares
- +1,201
- Change %
- Price
- $83.24
- Shares after
- 1,201
- Date
- 10 Jun 2021
- Ownership
- Direct
- Underlying class
- Class A common stock
- Underlying amount
- 1,201
- Exercise price
- $146.01
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The options vest in 4 equal installments on September 10, 2021, December 10, 2021, March 10, 2022, and June 10, 2022, subject to continued service through each vesting date.
Footnote F2
The options vest in the following installments: 300 shares on September 10, 2021, December 10, 2021 and March 10, 2022, respectively, and 301 shares June 10, 2022, subject to continued service through each vesting date.
Footnote F3
This option was issued to the reporting person pursuant to the Reata Non-Employee Director Compensation Policy in lieu of future director fees of $100,000.